Abstracts

Citation

Can the Specimen Adequacy Control (SAC) in Cepheid Xpert® CT/NG predict infection?.

Citation

Coleen Cunningham, Ulla Buchholz, Petronella Muresan, Elizabeth McFarland, Cindy Luongo, Peter Collins, Bhavin Thumar, Betty Schappell, Devasena Gnanashanmugam, George Siberry, Vivian Rexroad, Ruth Karron. Safety and Immunogenicity of the Recombinant Live-Attenuated Respiratory syncytial Virus Vaccine RSV cps2 in RSV-seronegative Infants and Children. Presented at: IDWeek 2015.

Citation

Elizabeth J. McFarland, Ursula Buchholz, Petronella Muresan, Coleen Cunningham, Cindy Luongo, Bhagvanji Thumar, Peter Collins, Charlotte Perlowski, Megan Valentine, Elizabeth Schappell, Devasena Gnanashanmugam, George Siberry, Marc Teitelbaum, Vivian Rexroad, Emily Barr, Paul Harding, Alexandria DiPerna, Ruth Karron. High infectivity of recombinant live-attenuated respiratory syncytial virus vaccine (RSV LID delta M2-2) in infants and children. Presented at: IDWeek 2015; 2015 Oct 07.

Citation

Jos Lommerse, Diana F Clarke, Anne Chain, Han Witjes, Hedy Teppler, Edmund Capparelli, Edward P Acosta, Matthew Rizk, Larissa Wenning, Thomas Kerbusch, Stephen A Spector, Betsy Smith, Mark Mirochnick. Ralteravir dosing in neonates (IMPAACT P1110) Use of Allometry and maturation in PK modeling to develop a daily dosing regimen for investigation during the first weeks of life. Presented at: Population Approach Group in Europe (PAGE) Meeting.

Citation

Jos Lommerse, Diana F Clarke, Anne Chain, Han Witjes, Hedy Teppler, Edmund Capparelli, Edward P Acosta, Matthew Rizk, Larissa Wenning, Thomas Kerbusch, Stephen A Spector, Betsy Smith, Mark Mirochnick. Raltegravir dosing in neonates (IMPAACT P1110) – Use of allometry and PK modeling to develop a daily dosing regimen for investigation during first weeks of life. Presented at: Population Approach Group in Europe (PAGE) Meeting.

Citation

Joseph Chen, Jorge Pinto, Mark Mirochnick, Meredith Warshaw, Bonnie Zimmer, Vincent Carey, Betsy Smith, George Siberry, Tim R. Cressey, Stephen A. Spector , Edmund V. Capparelli for the IMPAACT P1083 Team. Population Pharmacokinetics of Lopinavir with WHO Weight Band Dosing - IMPAACT P1083. Presented at: ICAAC 2015; 2015 Sep 18.

Citation

Levin MJ, Lindsey JC, Kaplan SS, Schimana W, Lawrence J, Bwakura-Dangarembiziutsa M, Ogwu A, Chi B, Sato P, Siberry G, Nelson M, Hille D, Weinberg G, Weinberg A. Safety and Immunogenicity of Pentavalent Rotavirus Vaccine in HIV-Infected and HIV-Exposed Infants in Africa (IMPAACT P1072). Presented at: IDWeek 2015.

Citation

Kensuke Shoji, Brookie M. Best, Mark Mirochnick, Alice Stek, Jiajia Wang, Tim R. Cressey, David Shapiro, Edmund V. Capparelli for IMPAACT P1026s. Population Pharmacokinetic Assessment of Factors Associated with Tenofovir Clearance in Pregnant and Postpartum Women with HIV infection in IMPAACT P1026s. Presented at: ICAAC 2015.

Citation

Brookie M. Best, Alice Stek, Edmund Capparelli, Jiajia Wang, David Shapiro, Courtney Fletcher, Elizabeth Smith, Nahida Chakhtoura, Mark Mirochnick for the IMPAACT P1026 Protocol Team. Pregnancy-associated decrease in tenofovir exposure counteracted by concomitant lopinavir/ritonavir. Presented at: IAS 2015.

Citation

Y Huo, K Patel, G Scott, G Siberry, Russell B Van Dyke, W Shearer. Lymphocyte subsets among HIV-exposed uninfected infants from birth to 12 months of age in IMPAACT P1025 study. Presented at: 7th International Workshop on HIV Pediatrics 2015.